Ortho Clinical Diagnostics to Report Second Quarter 2021 Results on August 4, 2021

Rhea-AI Summary

Ortho Clinical Diagnostics (Nasdaq: OCDX) will release its second quarter 2021 results on August 4, 2021, after market close. A conference call is scheduled for the same day at 5:00 pm ET to discuss these results. Interested parties can access the call via the Company’s website or by phone. A replay will be available shortly after the event. Ortho Clinical Diagnostics, a leading in vitro diagnostics company, impacts over 800,000 patients daily with its innovative testing solutions, aiming to enhance patient care and laboratory efficiency.

RARITAN, N.J., July 23, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics companies, today announced it will report results for its second quarter 2021 ended July 4, 2021, after the market close on Wednesday, August 4, 2021.

Ortho Clinical Diagnostics will hold a conference call the same day at 5:00 pm ET to discuss the results. Interested parties can access the call and accompanying presentation on the “Investors” portion of the Company’s website at https://ir.orthoclinicaldiagnostics.com/. Presentation materials will also be posted to the “Investors” portion of the website at the time of the call. Those unable to access the webcast may join the call via phone by dialing 888-895-5271 (domestic) or 847-619-6547 (international) and entering Conference ID number 50202649.

A replay of the conference call will be available a few hours after the event on the “Investors” portion of the Company’s website, under the “Events” section.

About Ortho Clinical Diagnostics

Ortho Clinical Diagnostics (Nasdaq: OCDX) is one of the world’s largest pure-play in vitro diagnostics (IVD) companies dedicated to transforming patient care.

More than 800,000 patients across the world are impacted by Ortho’s tests each day. Because Every Test Is A Life™, Ortho provides hospitals, hospital networks, clinical laboratories and blood banks around the world with innovative technology and tools to ensure test results are fast, accurate, and reliable. Ortho's customized solutions enhance clinical outcomes, improve efficiency, overcome lab staffing challenges and reduce costs.

From launching the first product to determine Rh+ or Rh- blood type, developing the world’s first tests for the detection of antibodies against HIV and hepatitis C, introducing patented dry-slide technology and marketing the first U.S. Food and Drug Administration-authorized high-volume antibody and antigen tests for COVID-19, Ortho has been a pioneering leader in the IVD space for over 80 years.

The company is powered by Ortho Care™, an award-winning, holistic service and support program that ensures best-in-class technical, field and remote service and inventory support to laboratories in more than 130 countries and territories around the globe.  

For more information, visit Ortho’s website or social media channels: LinkedIn, Twitter, Facebook and YouTube. 

Investors:

IR@orthoclinicaldiagnostics.com

Media:

media@orthoclinicaldiagnostics.com

FAQ

When will Ortho Clinical Diagnostics report its second quarter 2021 results?

Ortho Clinical Diagnostics will report its second quarter 2021 results on August 4, 2021, after market close.

What time is the conference call for Ortho Clinical Diagnostics' Q2 results?

The conference call to discuss Ortho Clinical Diagnostics' Q2 results is scheduled for 5:00 pm ET on August 4, 2021.

How can I access the conference call for the Ortho Clinical Diagnostics Q2 results?

You can access the conference call for Ortho Clinical Diagnostics' Q2 results on their website or by dialing 888-895-5271 (domestic) or 847-619-6547 (international) with Conference ID 50202649.

Where can I find the replay of Ortho Clinical Diagnostics' conference call?

The replay of Ortho Clinical Diagnostics' conference call will be available on the 'Investors' section of their website a few hours after the event.

What is the significance of Ortho Clinical Diagnostics in the healthcare industry?

Ortho Clinical Diagnostics is one of the largest in vitro diagnostics companies, enhancing patient care and impacting over 800,000 patients globally each day.